Search

Your search keyword '"Lervang Hh"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Lervang Hh" Remove constraint Author: "Lervang Hh"
66 results on '"Lervang Hh"'

Search Results

1. Liraglutide and Renal Outcomes in Type 2 Diabetes

2. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

3. The effect of low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart disease

4. The acute effect of a single very high dose of n-3 fatty acids on coagulation and fibrinolysis

5. Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus

6. Long-term supplementation with n-3 fatty acids, II: effect on neutrophil and monocyte chemotaxis

7. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial

8. Long-term supplementation with n-3 fatty acids, I: Effect on blood lipids, haemostasis and blood pressure

10. The effect of n-3 polyunsaturated fatty acids on Lp(a)

11. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study.

13. Type 2 diabetes and pneumonia outcomes: a population-based cohort study.

15. Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy.

16. The degree of autonomic modulation is associated with the severity of microvascular complications in patients with type 1 diabetes.

17. Cardiovascular autonomic neuropathy is associated with macrovascular risk factors in type 2 diabetes: new technology used for routine large-scale screening adds new insight.

18. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

19. Change from oral antidiabetic therapy to insulin and risk of urinary tract infections in Type 2 diabetic patients: a population-based prescription study.

20. Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis.

21. Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis.

22. Disturbance of inorganic phosphate metabolism in diabetes mellitus: its impact on the development of diabetic late complications.

23. The North Jutland County Diabetic Retinopathy Study (NCDRS).

24. Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

25. The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.

26. The North Jutland County Diabetic Retinopathy Study: population characteristics.

27. Statin use and mortality within 180 days after bacteremia: a population-based cohort study.

28. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults.

29. [Insulin pump treatment in Denmark].

30. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study.

31. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study.

32. Can a cilio-retinal artery influence diabetic maculopathy?

33. [Photographic screening for diabetic retinopathy in the county of North Jutland. The first fully digitalized telemedicine-screening clinic].

34. Diabetes patients' ability to estimate dietary carbohydrate content for use in a decision support system.

35. [Type 2 diabetes--new treatment].

36. The effect of n-3 fatty acids on neutrophil chemiluminescence.

37. [Fish oils and rheumatoid arthritis. A randomized and double-blind study].

39. The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects.

40. [Short-term and long-term effects on glycosylated hemoglobin after transition from conventional insulin treatment to multiple insulin injection regime in a diabetic outpatient clinic].

41. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial.

42. Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids.

43. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy?

44. Long-term supplementation with n-3 fatty acids, I: Effect on blood lipids, haemostasis and blood pressure.

45. The effect of n-3 polyunsaturated fatty acids on Lp(a).

46. Renal sodium metabolism in relation to hypertension in diabetes.

47. Postpartum autoimmune thyroid disorder associated with HLA-DR4?

48. HLA-DR factors associated with postpartum hypothyroidism: an early manifestation of Hashimoto's thyroiditis?

49. [Hypothyroidism and serum enzyme].

50. Thyroid dysfunction after delivery: incidence and clinical course.

Catalog

Books, media, physical & digital resources